Skip to main content

Advertisement

Table 3 Patient profile

From: HIV-1 mutational pathways under multidrug therapy

Patient demographics
Age 1st genotyping 39.7 years ± 9.3
Gender (M/F) 1054 M 433 F
Num prev therps 4 (median) 0-32 (range)
Days between genotypings 485 (mean) 639 (variance)
Risk group:   
Heterosexual 450 30%
Homo/bisexual 367 25%
IVDA 372 25%
Vertical transmission 33 2%
Blood products 25 2%
Other/unknown 245 16%
  1. Background data on the subjects included in the study. When a subject has contributed multiple therapy records to the study, the demographic information is taken from the first therapy included.